Frontiers in Microbiology (Jul 2024)

Insights from metagenomics into gut microbiome associated with acute coronary syndrome therapy

  • Yuee Guan,
  • Shuru Zhao,
  • Jing Li,
  • Wenqian Zhang,
  • Wenqian Zhang,
  • Zhonghao Guo,
  • Yi Luo,
  • Xiaofei Jiang,
  • Jun Li,
  • Jianxiong Liu,
  • Xi Chen,
  • Zicheng Zhao,
  • Zhe Zhang,
  • Zhe Zhang

DOI
https://doi.org/10.3389/fmicb.2024.1369478
Journal volume & issue
Vol. 15

Abstract

Read online

Acute coronary syndrome (ACS) is a predominant cause of mortality, and the prompt and precise identification of this condition is crucial to minimize its impact. Recent research indicates that gut microbiota is associated with the onset, progression, and treatment of ACS. To investigate its role, we sequenced the gut microbiota of 38 ACS patients before and after percutaneous coronary intervention and statin therapy at three time points, examining differential species and metabolic pathways. We observed a decrease in the abundance of Parabacteroides, Escherichia, and Blautia in patients after treatment and an increase in the abundance of Gemalla, Klebsiella variicola, Klebsiella pneumoniae, and others. Two pathways related to sugar degradation were more abundant in patients before treatment, possibly correlated with disorders of sugar metabolism and risk factors, such as hyperglycemia, insulin resistance, and insufficient insulin secretion. Additionally, seven pathways related to the biosynthesis of vitamin K2 and its homolog were reduced after treatment, suggesting that ACS patients may gradually recover after therapy. The gut microbiota of patients treated with different statins exhibited notable differences after treatment. Rosuvastatin appeared to promote the growth of anti-inflammatory bacteria while reducing pro-inflammatory bacteria, whereas atorvastatin may have mixed effects on pro-inflammatory and anti-inflammatory bacteria while increasing the abundance of Bacteroides. Our research will provide valuable insights and enhance comprehension of ACS, leading to better patient diagnosis and therapy.

Keywords